Bolden Therapeutics
Phase 1Neurogenesis (the formation of new brain cells from endogenous neural stem cells) has been extensively studied and is believed to play an important role in learning and memory.
Founded
2021
Focus
RNA & Gene Therapy
About
Neurogenesis (the formation of new brain cells from endogenous neural stem cells) has been extensively studied and is believed to play an important role in learning and memory.
Funding History
7Total raised: $32.3M
Grant$505KNIAJul 31, 2024
Grant$397KNIAMar 13, 2023
Series A$25MMPM CapitalNov 15, 2022
Grant$406KNIASep 1, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile